Higher Iron Levels Increase Thromboembolism Risk
|
By HospiMedica International staff writers Posted on 31 Jul 2019 |
|
Image: A new study claims iron levels can influence VTE and infection risk (Photo courtesy of 123rf).
A new study reveals that although naturally higher blood serum iron levels reduce atherosclerosis, they also increase the risk of venous thromboembolism (VTE), stroke, and bacterial skin infection.
Researchers at Imperial College London (Imperial; United Kingdom), Bordeaux population health (France), the University of Ioannina (Greece), and other institutions conducted a study to investigate the effect of genetically determined iron status on carotid intima‐media thickness, carotid plaque, and VTE using a genome‐wide Mendelian randomization of relevant data from 48,972 subjects. Two‐sample summary data Mendelian randomization was performed for analysis.
The results revealed that higher genetically determined iron status was associated with increased risk of VTE and a higher risk of bacterial skin infection, with odds ratios per standard deviation (SD) increase in biomarker levels of 1.37 for serum iron, 1.25 for transferrin saturation, 1.92 for ferritin, and 0.76 for serum transferrin (with higher transferrin levels representing lower iron status). In contrast, higher iron status was also associated with lower risk of carotid plaque. The study was published on August 6, 2019, in the Journal of the American Heart Association.
“Iron is a crucial mineral in the body, and is essential for carrying oxygen around the body. However, getting the right amount of iron in the body is a fine balance; too little can lead to anemia, but too much can lead to a range of problems, including liver damage,” said lead author Dipender Gill, MD, PhD, of ICL. “The study only looked at naturally occurring iron levels in the body related to genetic variation between individuals, and did not investigate the effect of taking iron supplements.”
Mendelian randomization examines measured variation in genes of known function to study the causal effect of a modifiable exposure on disease in epidemiological studies of common genetic polymorphisms with well-understood effects on exposure patterns. The genotype must only affect the disease status indirectly via its effect on the exposure of interest. Mendelian randomization was first described as a method for obtaining unbiased estimates of the effects of a putative causal variable, without conducting a traditional randomized trial.
Related Links:
Imperial College London
Bordeaux population health
University of Ioannina
Researchers at Imperial College London (Imperial; United Kingdom), Bordeaux population health (France), the University of Ioannina (Greece), and other institutions conducted a study to investigate the effect of genetically determined iron status on carotid intima‐media thickness, carotid plaque, and VTE using a genome‐wide Mendelian randomization of relevant data from 48,972 subjects. Two‐sample summary data Mendelian randomization was performed for analysis.
The results revealed that higher genetically determined iron status was associated with increased risk of VTE and a higher risk of bacterial skin infection, with odds ratios per standard deviation (SD) increase in biomarker levels of 1.37 for serum iron, 1.25 for transferrin saturation, 1.92 for ferritin, and 0.76 for serum transferrin (with higher transferrin levels representing lower iron status). In contrast, higher iron status was also associated with lower risk of carotid plaque. The study was published on August 6, 2019, in the Journal of the American Heart Association.
“Iron is a crucial mineral in the body, and is essential for carrying oxygen around the body. However, getting the right amount of iron in the body is a fine balance; too little can lead to anemia, but too much can lead to a range of problems, including liver damage,” said lead author Dipender Gill, MD, PhD, of ICL. “The study only looked at naturally occurring iron levels in the body related to genetic variation between individuals, and did not investigate the effect of taking iron supplements.”
Mendelian randomization examines measured variation in genes of known function to study the causal effect of a modifiable exposure on disease in epidemiological studies of common genetic polymorphisms with well-understood effects on exposure patterns. The genotype must only affect the disease status indirectly via its effect on the exposure of interest. Mendelian randomization was first described as a method for obtaining unbiased estimates of the effects of a putative causal variable, without conducting a traditional randomized trial.
Related Links:
Imperial College London
Bordeaux population health
University of Ioannina
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Medical Examination & Procedure Light
Vega 80
New
Tourniquet System
heidi– mein Tourniquet
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
